SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-003293
Filing Date
2022-03-10
Accepted
2022-03-10 07:35:36
Documents
15
Period of Report
2022-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dyn-20220310.htm   iXBRL 8-K 63867
2 EX-99.1 dyn-ex99_1.htm EX-99.1 137606
3 GRAPHIC img259164492_0.jpg GRAPHIC 34220
4 GRAPHIC img259164492_1.jpg GRAPHIC 34220
  Complete submission text file 0000950170-22-003293.txt   430691

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyn-20220310.xsd EX-101.SCH 2494
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyn-20220310_pre.xml EX-101.PRE 11152
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyn-20220310_lab.xml EX-101.LAB 17858
9 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20220310_htm.xml XML 4699
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 22727418
SIC: 2834 Pharmaceutical Preparations